Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Inhaler Stories

2013-06-19 12:26:30

DALLAS, June 19, 2013 /PRNewswire/ -- The Report "European Drug Delivery Technology Market (Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017" analyzes and studies the major market drivers, restraints and opportunities in the following Regions: - Germany - France - United Kingdom -...

2013-06-07 16:24:09

MADISON, Wis., June 7, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-?-lis), the FDA-cleared mobile health solution for asthma and COPD, today announces it received a second investment from the California HealthCare Foundation (CHCF). Asthmapolis is designed to improve the care of people with asthma and COPD, advance understanding of symptoms and triggers and help them achieve control of these diseases. The CHCF investment in Asthmapolis, which now totals $1,047,000, is directed at helping to...

2013-06-06 23:19:56

[300 Pages Report] The European Drug Delivery Technologies Market report categorizes the European Market by Technologies (Oral, Pulmonary, Injectable, Ocular, Transdermal, Nasal, Topical, Implantable, and Transmucosal Drug Delivery), & by Geography. (PRWEB) June 06, 2013 The "European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release,...

2013-06-06 08:29:51

TEL AVIV, Israel, June 6, 2013 /PRNewswire/ -- Inspiro Medical [http://www.inspiromedical.com ], a portfolio company of The Trendlines Group, recently completed a successful clinical trial for InspiromaticTM, its innovative, breath-synchronized, active dry powder inhaler. The study, completed in May 2013 at Schneider Medical Center aimed to objectively assess, in a randomized, crossover, double blind study, the efficacy and safety profiles of formoterol (bronchodilator)...

2013-05-22 04:21:01

OXFORD, England, May 22, 2013 /PRNewswire/ -- First patients dosed with PSX1002, an orally inhaled, novel drug-only formulation of glycopyrronium bromide designed using Prosonix' particle engineering platform Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung...

2013-05-21 08:29:37

Boehringer Ingelheim also presents new data from a Phase 2 study demonstrating increased bronchodilation with 5 mcg tiotropium as an add-on therapy in symptomatic patients with moderate persistent asthma at the American Thoracic Society International Conference (ATS 2013) RIDGEFIELD, Conn., May 21, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of...

2013-05-20 08:25:53

MADISON, Wis., May 20, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, today announced CEO David Van Sickle will give an invited presentation during Respiratory Drug Delivery (RDD(®)) Europe 2013 in Berlin, Germany. On Friday, May 24 at 8:30 a.m., Van Sickle will present "Monitoring and Improving Compliance and Asthma Control: Mapping Inhaler Use for Feedback to Patients, Physicians and Payers" as part of the session track,...

2013-05-17 08:23:49

Data on investigational compounds and an approved product will be presented RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference (ATS 2013) in Philadelphia, PA, May 17 - 22.( )Data will highlight research conducted with a product approved for the treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler®...

2013-05-17 08:23:25

Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray will become the only available short-acting bronchodilator offering two different medicines in a single inhaler RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals (HCPs) and patients that the transition...

2013-05-02 23:22:13

[316 Pages Report] Drug Delivery Technology Market Report categorizes the Global Market by Metered Dose Inhalers, Auto Injectors, Transdermal Patches, Drug Eluting Stentscand Infusion Pumps Forecasting - 2017. (PRWEB) May 02, 2013 The "Drug Delivery Technology Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017," analyzes and...